This implies that cancers driven by KRAS may be more susceptible to the PCAIs as the essential polyisoprenyl-driven functional interactions may be more easily uncoupled than would be the case for the other RAS proteins that are farnesylated and palmitoylated [27]. The gene discussed is KRAS; the disease is cancer.